Patents by Inventor Peter Richard Strack

Peter Richard Strack has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treating cancer with a combination of a PD-1 antagonist and dinaciclib
    Patent number: 9827309
    Abstract: The present disclosure describes combination therapies comprising an antagonist of Programmed Death 1 receptor (PD-1) and the CDK inhibitor dincaciclib, and the use of the combination therapies for the treatment of cancer, and in particular for treating cancers that express PD-L1.
    Type: Grant
    Filed: August 15, 2014
    Date of Patent: November 28, 2017
    Assignee: Merck Sharp & Dohme Corp.
    Inventors: Peter Richard Strack, Robert Booher, Venkataraman Sriram, Joseph H. Phillips
  • TREATING CANCER WITH A COMBINATION OF A PD-1 ANTAGONIST AND DINACICLIB
    Publication number: 20160193334
    Abstract: The present disclosure describes combination therapies comprising an antagonist of Programmed Death 1 receptor (PD-1) and the CDK inhibitor dincaciclib, and the use of the combination therapies for the treatment of cancer, and in particular for treating cancers that express PD-L1.
    Type: Application
    Filed: August 15, 2014
    Publication date: July 7, 2016
    Applicant: MERCK SHARP & DOHME CORP.
    Inventors: Peter Richard Strack, Robert Booher, Venkataraman Sriram, Joseph H. Phillips
  • COMPOSITIONS AND METHODS FOR TREATING CANCER
    Publication number: 20160130659
    Abstract: The instant invention relates to methods for the treatment of B-cell lymphomas and leukemia by administering a SYK inhibitor. In another embodiment, the invention relates to a method for treating a patient diagnosed with a B-cell lymphoma or leukemia, comprising administering a SYK inhibitor, wherein the B-cells of said patient to be treated are characterized by elevated expression levels of CD86.
    Type: Application
    Filed: June 3, 2014
    Publication date: May 12, 2016
    Applicant: Merck Sharp & Dohme Corp.
    Inventors: Kenzie MacIsaac, Manfred Kraus, Peter Richard Strack, Kumiko Nagashima, John Michael Ellis